Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

By LabMedica International staff writers
Posted on 26 Sep 2024

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements. Professional forums and their accompanying stage programs will delve into health IT, medical technology trends, healthcare policy, and laboratory medicine. Among the highlights is the MEDICA LABMED FORUM, known for its informative lectures and expert panel discussions, which has become a key feature of the MEDICA program. Around 6,000 companies have secured their spots at MEDICA 2024 and COMPAMED 2024, the concurrent supplier trade fair. Last year, both events together attracted a total of 83,000 visitors.

This year, the focus is on massive digitalization, networking, big data applications, and artificial intelligence (AI), collectively referred to as "Lab 4.0." On November 11, the opening day of MEDICA 2024, the MEDICA LABMED FORUM will address the hot topic of digitalization and AI. The morning session will concentrate on the shortage of skilled personnel, a pressing issue in laboratory medicine. Panelists will explore how automation and digitalization could help resolve this crisis. The afternoon session will shift to AI and big data tools that are either currently available or in development. Discussions will cover image recognition through deep learning, now standard for automated leucogram analysis, and the developmental state of machine learning for handling the vast multivariate data sets in laboratory diagnostics. A key question will be whether large language models can clarify complex lab findings and whether AI is making us smarter or dumber.

On the second day, discussions will focus on developments in laboratory medicine regarding cardiovascular diseases and cancer, the leading causes of mortality in the Western world. The cardiology section will highlight congenital heart defects, which are increasingly surgically correctable in childhood and are becoming more prominent in adult medicine due to extended life expectancy. Speakers will provide a clinical perspective and demonstrate the potential of machine learning in modern data evaluation. The afternoon session will cover highly sensitive cancer diagnostics using blood, known as “liquid biopsy,” which is revolutionizing oncology by allowing closer monitoring of tumor progression than conventional tissue biopsies. The session will also explore new techniques like analyzing methylation profiles for early detection of hereditary cancer forms and single-cell analysis using microfluidics.

On Young Scientists' Day, the next generation of researchers will present their perspectives on the future of laboratory medicine, offering insights into the latest advancements and challenges. Topics will include wearables for continuous diagnostic monitoring and the ongoing shortage of skilled personnel. The afternoon will feature discussions on personalized therapy based on individual laboratory parameters, the integration of laboratory and imaging diagnostics, and the role of AI in these fields.

The forum’s final day traditionally focuses on diagnostic research institutes and companies looking to introduce new applications in laboratory medicine. The theme for 2024 will center on aging, with sessions examining pathophysiology, diagnostics, and treatment. Topics will include the genetic and epigenetic factors influencing biological aging, protein misfolding as a basis for neurodegenerative diseases like Alzheimer's and Parkinson's, and the role of gut microbiota in strokes. As the forum’s "grand finale," discussions will address theories and practical approaches to slowing the aging process, such as anti-aging drugs, the effects of anti-inflammatory agents, environmental influences on aging in the central nervous system, and methods for repairing nervous system lesions.

Related Links:
MEDICA

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
Immunofluorescence Analyzer
MPQuanti
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.